Mycobacterium avium complex and Cryptococcus neoformans co-infection in a patient with acquired immunodeficiency

Emilien Gregoire1, Benoit François Pirotte1, Filip Moerman1

  • 1Department of Internal Medicine and Infectious Diseases, Centre Hospitalier Régional (CHR), Liege, Belgium.

Acta Clinica Belgica
|April 22, 2021
PubMed
Abstract

Insights

Concurrent Cryptococcus neoformans and Mycobacterium avium complex infections are rare but can occur in advanced human immunodeficiency virus (HIV) infection. Early diagnosis and treatment of these opportunistic infections are crucial for patient recovery.

Area of Science:

  • Infectious Diseases
  • Immunology
  • HIV Medicine

Background:

  • Opportunistic infections (OIs) are a significant concern in patients with acquired immunodeficiency syndrome (AIDS).
  • Cryptococcus neoformans and Mycobacterium avium complex (MAC) are common OIs, but their concurrent occurrence is rare.
  • This case highlights the potential for co-infection even in high-income countries.

Observation:

  • A 28-year-old patient with advanced human immunodeficiency virus (HIV) infection (CD4 count of 10 cells/µL) presented with fever, headache, and wasting.
  • Disseminated Cryptococcus neoformans infection was diagnosed via positive serum cryptococcal antigen and blood/CSF cultures.
  • Disseminated Mycobacterium avium complex (MAC) infection was confirmed by positive lymph node biopsy culture.

Findings:

  • The patient was diagnosed with concurrent disseminated Cryptococcus neoformans and Mycobacterium avium complex infections.
  • Treatment with antiretroviral therapy (ART) and specific OI medications led to a good clinical outcome.
  • This represents one of the few reported cases of this co-infection in the post-ART era.

Implications:

  • Clinicians must maintain a high index of suspicion for co-infections in severely immunocompromised patients, including those with newly diagnosed AIDS.
  • Prompt identification and management of all OIs are essential for successful treatment outcomes in advanced HIV.
  • Early HIV detection and treatment remain critical for preventing AIDS and its life-threatening complications.

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
1.4K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
451
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
568
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
257
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
802
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
305